BR Form 4: CEO Timothy Gokey Disposes 5,674 Shares via 10b5-1 Plan
Rhea-AI Filing Summary
Timothy C. Gokey, CEO of Broadridge Financial Solutions (BR), reported an open-market sale of 5,674 shares on 08/25/2025 under a 10b5-1 trading plan adopted May 14, 2025. The filing shows a weighted-average sale price of $258.3733, with execution prices ranging from $256.24 to $262.46. After the reported dispositions, Mr. Gokey beneficially owned 143,285.0271 shares, held directly. The Form 4 was filed as a single reporting-person filing and was signed by a power of attorney on 08/26/2025. The report includes an undertaking to provide detailed per-price sale information upon request.
Positive
- Transaction executed under a 10b5-1 plan, indicating pre-arranged and compliant insider trading
- Weighted-average price and execution range disclosed, with offer to provide per-price details on request
- Form 4 filed by one reporting person and executed via power of attorney, showing proper procedural compliance
Negative
- CEO reduced direct ownership by 5,674 shares, lowering his stake to 143,285.0271 shares
- Insider sale may be perceived negatively by some investors despite being pre-planned
Insights
TL;DR: Routine insider sale under a pre-established 10b5-1 plan; shows compliance and transparency but reduces the CEO's direct stake modestly.
The sale of 5,674 shares was executed pursuant to a 10b5-1 plan, which signals pre-planned disposition rather than opportunistic trading. That supports governance best practices by reducing potential concerns about trading on non-public information. The filing discloses weighted-average price and the range of execution prices and offers to provide per-price details, which is thorough disclosure. The remaining direct beneficial ownership of ~143.3k shares remains significant but is reduced by the sale. Overall, this is procedurally compliant and informational for shareholders.
TL;DR: Small-scale, pre-planned insider sale; unlikely to be materially market-moving given the quantity and disclosure.
The transaction quantity (5,674 shares) and the disclosed weighted-average price ($258.3733) indicate a routine disposition. The seller used a 10b5-1 plan adopted May 14, 2025, which typically mitigates timing concerns. The filing reports post-sale direct beneficial ownership of 143,285.0271 shares, which provides context on the CEO's remaining exposure to the company. From a market-impact perspective, this single, disclosed sale is unlikely to change investor valuation materially.